BIOMAT Database Logo BIOMAT Database Logo

Phenformin and ethyloestrenol for Raynaud's disease. 1969

G R Fearnley, and R Chakrabarti

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D010973 Platelet Adhesiveness The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces. Adhesiveness, Platelet,Adhesivenesses, Platelet,Platelet Adhesivenesses
D011928 Raynaud Disease An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress. Cold Fingers, Hereditary,Raynaud Phenomenon,Raynaud's Disease,Raynauds Disease
D005032 Ethylestrenol An anabolic steroid with some progestational activity and little androgenic effect. Ethyloestrenol,Maxibolin
D005260 Female Females
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G R Fearnley, and R Chakrabarti
Phenformin and ethyloestrenol for Raynaud's disease.
November 1969, Lancet (London, England),
G R Fearnley, and R Chakrabarti
Phenformin and ethyloestrenol in scleroderma.
May 1972, Lancet (London, England),
G R Fearnley, and R Chakrabarti
Phenformin and ethyloestrenol in recurrent venous thrombosis.
January 1975, Acta medica Scandinavica,
G R Fearnley, and R Chakrabarti
Treatment of Behcet's syndrome with phenformin and ethyloestrenol.
June 1969, Lancet (London, England),
G R Fearnley, and R Chakrabarti
Phenformin and ethyloestrenol in recurrent deep venous thrombosis (DVT).
January 1976, Folia haematologica (Leipzig, Germany : 1928),
G R Fearnley, and R Chakrabarti
Treatment of haemolytic-uraemic syndrome with phenformin and ethyloestrenol.
November 1971, Lancet (London, England),
G R Fearnley, and R Chakrabarti
The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
January 1972, Acta Universitatis Carolinae. Medica. Monographia,
G R Fearnley, and R Chakrabarti
Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
January 1970, Scandinavian journal of haematology,
G R Fearnley, and R Chakrabarti
Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
July 1972, Journal of clinical pathology,
G R Fearnley, and R Chakrabarti
Effect of phenformin and ethyloestrenol on blood fibrinolytic activity on rabbits maintained on high cholesterol diet.
June 1976, The Indian journal of medical research,
Copied contents to your clipboard!